Recent guidelines on weight-loss drugs are a ‘groundbreaking’ shift in obesity treatment – The Irish Times
The Weight of Change: How New Drugs and a Reframed Understanding are Reshaping Obesity Treatment The conversation around weight loss has fundamentally shifted. For decades, the focus remained squarely on willpower and lifestyle changes. Now, thanks to the arrival of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and a landmark shift in perspective from the … Read more